A Study Evaluating the Safety and Efficacy of Bempedoic Acid Plus Ezetimibe Fixed-Dose Combination Compared to Bempedoic Acid, Ezetimibe, and Placebo in Patients Treated With Maximally Tolerated Statin Therapy
Clinical trial NCT03337308 · COMPLETED
Trial details
- NCT number
- NCT03337308
- Sponsor
- Esperion Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-23
- Primary completion
- 2018-06-18
- Enrollment
- 382
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.